Latest 10-K annual reports

Nauticus Robotics, Inc. filed its annual report detailing its capital stock structure, financial performance for the fiscal year ended December 31, 2025, and ongoing business strategies.

Natures Miracle Holding Inc. experienced an 81.2% decrease in revenue for the fiscal year ended December 31, 2025, primarily due to inventory constraints.

QVC Group, Inc. has filed its annual report for the fiscal year ended December 31, 2025, detailing significant financial challenges, including substantial impairments and a planned Chapter 11 filing.

My Size, Inc. filed its annual report detailing a net loss of $5.85 million for 2025, while highlighting strategic acquisitions and growth initiatives in fashion technology.

Q/C Technologies, Inc. (formerly TNF Pharmaceuticals, Inc.) has filed a description of its capital stock, outlining authorized shares, common and preferred stock details, and the rights associated with each class.

ENvue Medical, Inc. (formerly NanoVibronix, Inc.) filed its annual report detailing significant operational changes, including a merger and reverse stock splits, while addressing Nasdaq listing requirements and ongoing financial challenges.

CytoSorbents Corporation has filed an amendment to its 2025 Form 10-K, primarily to include Part III disclosures and updated executive certifications.

CirTran Corporation's 2025 Form 10-K details significant revenue growth, ongoing operational challenges, and a going concern warning from auditors.

Vivakor, Inc. filed its annual report detailing a significant revenue increase but also substantial operating losses and a going concern warning.

Mitesco, Inc. reports a strategic pivot towards data center services and AI applications, while continuing debt restructuring efforts and addressing internal control weaknesses.

Drugs Made In America Acquisition Corp. reports management turnover, material internal control weaknesses, and a potential $1 billion de-SPAC target.

Atlantic International Corp. (ATLN) filed its annual report for the fiscal year ended December 31, 2025, detailing a 1.5% decrease in service revenue and a significant increase in SG&A expenses.

United Health Products reports continued operating losses and significant regulatory hurdles as it seeks FDA approval for its CelluSTAT hemostatic gauze.

Mannatech reports a net loss of $15.2 million for 2025, citing declining sales and significant non-cash tax charges.

Nocera, Inc. reports a net loss of $2.88 million for fiscal year 2025, citing ongoing operational challenges and substantial doubt regarding its ability to continue as a going concern.

American Strategic Investment Co. reports a net loss of $21.2 million for 2025 amid ongoing debt covenant breaches and a strategic shift away from REIT status.

LQR House reports a net loss of $25.5 million for 2025 while navigating significant legal settlements and strategic shifts in its alcohol e-commerce and marketing business.

CDT Equity Inc. files its annual report detailing its securities, corporate governance, financial metrics, and future outlook, highlighting ongoing development and strategic partnerships.

Solidion Technology, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing its progress in advanced battery technology development and commercialization.

Vivos Therapeutics, Inc. announced its fiscal year 2025 results, showing a 16% increase in total revenue to $17.4 million, driven by growth in sleep testing services and treatment revenue, despite a decline in product sales.

Digital Brands Group reports a significant net loss of $28.3 million for 2025 amid a strategic pivot toward collegiate NIL apparel and continued liquidity challenges.

Rain Enhancement Technologies Holdco, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing operational progress, financial results, and ongoing efforts to maintain Nasdaq listing.

Traws Pharma, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing progress in its viral disease and oncology programs, alongside financial performance and future outlook.

Versus Systems reports significant revenue growth driven by a related-party license agreement while disclosing material weaknesses in internal controls and ongoing going concern risks.

Global Asset Management Group transitioned into a diversified holding company in 2025 through the acquisitions of Bella Rio Marketing Agency and DC Rental Portfolio Corp.

Boxlight Corporation reports a 19.6% revenue decline for fiscal year 2025 amid ongoing liquidity and debt challenges.

I-ON Digital Corp. reports increased revenue from its gold-backed digital asset platform while highlighting significant going concern risks and internal control weaknesses.

Skytech Orion Global Corp. (formerly Citrine Global Corp.) has officially transitioned its strategic focus to the defense and drone sectors, detailing its operational plans and financial status in its latest 10-K filing.

Cosmos Health reports 2025 revenue growth to $65.3 million while highlighting ongoing going concern risks and material weaknesses in internal controls.

urban-gro, Inc. has completed its merger with Flash Sports & Media, Inc., transitioning from a legacy CEA services firm to a diversified sports, media, and experiential marketing platform.